Physician profile
Amy Huber
NPI 1215904602
$4,823.60
in general payments reported to CMS, 2019-2025
21 companies · $1,018 in 2025
The $1,018 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $233 · 2021: $524 · 2022: $922 · 2023: $560 · 2024: $1,153 · 2025: $1,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,658 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,658.25 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $855.53 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $849.82 | 2019-2025 | |
| Janssen Biotech, INC. | $799.21 | 2020-2025 | Tremfya, Stelara, Simponi |
| Genzyme Corporation | $497.50 | 2020-2025 | |
| Sun Pharmaceutical Industries INC. | $403.75 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $344.22 | 2019-2025 | Dupixent |
| Genentech USA, INC. | $226.80 | 2019-2022 | |
| Incyte Corporation | $132.98 | 2023-2025 | Opzelura |
| Arcutis Biotherapeutics, INC. | $123.20 | 2023-2025 | Zoryve |
| Lilly USA, LLC | $107.08 | 2020-2025 | Taltz, Ebglyss |
| E.R. Squibb & Sons, L.L.C. | $88.67 | 2022-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $69.68 | 2019-2025 | Nemluvio |
| Pfizer INC. | $68.27 | 2019-2025 | |
| Ucb, INC. | $57.04 | 2021-2023 | Cimzia |
| Misonix INC | $50.71 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $39.25 | 2022-2023 | Adbry |
| Mayne Pharma Commercial LLC | $25.99 | 2021 | |
| Organogenesis INC. | $23.48 | 2025 | Novachor |
| Botanix Sb INC | $23.33 | 2025 | Sofdra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.76 | 2021 | |
| Blueprint Medicines Corporation | $15.33 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Huber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.